Kas, B., Talbot, H., Ferrara, R., Richard, C., Lamarque, J., Pitre-Champagnat, S., . . . Caramella, C. (2020). Clarification of Definitions of Hyperprogressive Disease During Immunotherapy for Non–Small Cell Lung Cancer. JAMA Oncol.
Stile di citazione ChicagoKas, Baptiste, et al. "Clarification of Definitions of Hyperprogressive Disease During Immunotherapy for Non–Small Cell Lung Cancer." JAMA Oncol 2020.
Citazione MLAKas, Baptiste, et al. "Clarification of Definitions of Hyperprogressive Disease During Immunotherapy for Non–Small Cell Lung Cancer." JAMA Oncol 2020.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.